The third division corresponds to modulatory SPNs, which express slow-acting neurotransmitters and/or neuropeptides and are distributed throughout the hypothalamus, midbrain and brainstem.
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been ...